Do analysts prefer ENSC or PYRGF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media refer more to ENSC or PYRGF?

In the previous week, Ensysce Biosciences had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Ensysce Biosciences and 1 mentions for PyroGenesis Canada. Ensysce Biosciences' average media sentiment score of 0.47 beat PyroGenesis Canada's score of 0.00 indicating that Ensysce Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ensysce Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate UG or ENSC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score United-Guardian 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer MIRA or ENSC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate TAOX or ENSC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synaptogenix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor TAOX or ENSC?

In the previous week, Synaptogenix and Synaptogenix both had 2 articles in the media. Synaptogenix's average media sentiment score of 0.76 beat Ensysce Biosciences' score of 0.47 indicating that Synaptogenix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synaptogenix 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ensysce Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BGM or ENSC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ensysce Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, BGM or ENSC?

Ensysce Biosciences has lower revenue, but higher earnings than BGM Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BGM Group $47.90M 0.52 -$19.94M N/A N/A Ensysce Biosciences $5.07M 1.85 -$10.18M -$2.76 N/A

Does the media favor BGM or ENSC?

In the previous week, BGM Group had 1 more articles in the media than Ensysce Biosciences. MarketBeat recorded 3 mentions for BGM Group and 2 mentions for Ensysce Biosciences. BGM Group's average media sentiment score of 0.67 beat Ensysce Biosciences' score of 0.47 indicating that BGM Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BGM Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ensysce Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Ensysce Biosciences (ENSC) Competitors

$0.48 -0.01 (-1.13%)

Closing price 09/14/2026 04:00 PM Eastern

Extended Trading

$0.47 -0.01 (-2.37%)

As of 06:46 AM Eastern

Compare

ENSC vs. PYRGF, UG, MIRA, TAOX, and BGM

Should you buy Ensysce Biosciences stock or one of its competitors? Ensysce Biosciences's main competitors and comparable companies include PyroGenesis Canada (PYRGF), United-Guardian (UG), MIRA Pharmaceuticals (MIRA), Synaptogenix (TAOX), and BGM Group (BGM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Ensysce Biosciences compare to PyroGenesis Canada?

Ensysce Biosciences (NASDAQ:ENSC) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

In the previous week, Ensysce Biosciences had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 2 mentions for Ensysce Biosciences and 1 mentions for PyroGenesis Canada. Ensysce Biosciences' average media sentiment score of 0.47 beat PyroGenesis Canada's score of 0.00 indicating that Ensysce Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ensysce Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PyroGenesis Canada has a net margin of -115.14% compared to Ensysce Biosciences' net margin of -280.53%. PyroGenesis Canada's return on equity of 0.00% beat Ensysce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ensysce Biosciences	-280.53%	-2,550.30%	-320.49%
PyroGenesis Canada	-115.14%	N/A	-60.81%

Ensysce Biosciences has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, PyroGenesis Canada has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ensysce Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

5.6% of Ensysce Biosciences shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 2.8% of Ensysce Biosciences shares are held by company insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Ensysce Biosciences has higher earnings, but lower revenue than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Ensysce Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ensysce Biosciences	$5.07M	1.85	-$10.18M	-$2.76	N/A
PyroGenesis Canada	$9.14M	3.47	-$21.12M	-$0.04	N/A

Summary

Ensysce Biosciences and PyroGenesis Canada tied by winning 7 of the 14 factors compared between the two stocks.

How does Ensysce Biosciences compare to United-Guardian?

United-Guardian (NASDAQ:UG) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

United-Guardian has a net margin of 22.01% compared to Ensysce Biosciences' net margin of -280.53%. United-Guardian's return on equity of 22.24% beat Ensysce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
United-Guardian	22.01%	22.24%	19.12%
Ensysce Biosciences	-280.53%	-2,550.30%	-320.49%

23.2% of United-Guardian shares are owned by institutional investors. Comparatively, 5.6% of Ensysce Biosciences shares are owned by institutional investors. 29.0% of United-Guardian shares are owned by company insiders. Comparatively, 2.8% of Ensysce Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

United-Guardian has higher revenue and earnings than Ensysce Biosciences. Ensysce Biosciences is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United-Guardian	$10.55M	3.12	$2.11M	$0.54	13.26
Ensysce Biosciences	$5.07M	1.85	-$10.18M	-$2.76	N/A

United-Guardian has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, Ensysce Biosciences has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United-Guardian	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ensysce Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Ensysce Biosciences had 1 more articles in the media than United-Guardian. MarketBeat recorded 2 mentions for Ensysce Biosciences and 1 mentions for United-Guardian. United-Guardian's average media sentiment score of 1.89 beat Ensysce Biosciences' score of 0.47 indicating that United-Guardian is being referred to more favorably in the media.

Company	Overall Sentiment
United-Guardian	Very Positive
Ensysce Biosciences	Neutral

Summary

United-Guardian beats Ensysce Biosciences on 12 of the 14 factors compared between the two stocks.

How does Ensysce Biosciences compare to MIRA Pharmaceuticals?

MIRA Pharmaceuticals (NASDAQ:MIRA) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Ensysce Biosciences has higher revenue and earnings than MIRA Pharmaceuticals. MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Ensysce Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MIRA Pharmaceuticals	N/A	N/A	-$10.44M	-$1.24	N/A
Ensysce Biosciences	$5.07M	1.85	-$10.18M	-$2.76	N/A

MIRA Pharmaceuticals has a beta of 1.52, meaning that its stock price is 52% more volatile than the broader market. Comparatively, Ensysce Biosciences has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

In the previous week, Ensysce Biosciences had 1 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 2 mentions for Ensysce Biosciences and 1 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 1.89 beat Ensysce Biosciences' score of 0.47 indicating that MIRA Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
MIRA Pharmaceuticals	Very Positive
Ensysce Biosciences	Neutral

35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 5.6% of Ensysce Biosciences shares are held by institutional investors. 19.9% of MIRA Pharmaceuticals shares are held by company insiders. Comparatively, 2.8% of Ensysce Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

MIRA Pharmaceuticals has a net margin of 0.00% compared to Ensysce Biosciences' net margin of -280.53%. MIRA Pharmaceuticals' return on equity of -106.95% beat Ensysce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MIRA Pharmaceuticals	N/A	-106.95%	-104.18%
Ensysce Biosciences	-280.53%	-2,550.30%	-320.49%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MIRA Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Ensysce Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

MIRA Pharmaceuticals beats Ensysce Biosciences on 10 of the 14 factors compared between the two stocks.

How does Ensysce Biosciences compare to Synaptogenix?

Synaptogenix (NASDAQ:TAOX) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

10.3% of Synaptogenix shares are held by institutional investors. Comparatively, 5.6% of Ensysce Biosciences shares are held by institutional investors. 2.7% of Synaptogenix shares are held by company insiders. Comparatively, 2.8% of Ensysce Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Ensysce Biosciences has higher revenue and earnings than Synaptogenix. Synaptogenix is trading at a lower price-to-earnings ratio than Ensysce Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synaptogenix	$300K	97.24	-$28.74M	-$3.85	N/A
Ensysce Biosciences	$5.07M	1.85	-$10.18M	-$2.76	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synaptogenix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ensysce Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Synaptogenix has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Ensysce Biosciences has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

In the previous week, Synaptogenix and Synaptogenix both had 2 articles in the media. Synaptogenix's average media sentiment score of 0.76 beat Ensysce Biosciences' score of 0.47 indicating that Synaptogenix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synaptogenix	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Ensysce Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Ensysce Biosciences has a net margin of -280.53% compared to Synaptogenix's net margin of -2,153.97%. Synaptogenix's return on equity of -128.51% beat Ensysce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synaptogenix	-2,153.97%	-128.51%	-97.54%
Ensysce Biosciences	-280.53%	-2,550.30%	-320.49%

Summary

Synaptogenix and Ensysce Biosciences tied by winning 6 of the 12 factors compared between the two stocks.

How does Ensysce Biosciences compare to BGM Group?

BGM Group (NASDAQ:BGM) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

In the previous week, BGM Group had 1 more articles in the media than Ensysce Biosciences. MarketBeat recorded 3 mentions for BGM Group and 2 mentions for Ensysce Biosciences. BGM Group's average media sentiment score of 0.67 beat Ensysce Biosciences' score of 0.47 indicating that BGM Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BGM Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Ensysce Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

BGM Group has a net margin of 0.00% compared to Ensysce Biosciences' net margin of -280.53%. BGM Group's return on equity of 0.00% beat Ensysce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BGM Group	N/A	N/A	N/A
Ensysce Biosciences	-280.53%	-2,550.30%	-320.49%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BGM Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ensysce Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BGM Group has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market. Comparatively, Ensysce Biosciences has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market.

5.6% of Ensysce Biosciences shares are held by institutional investors. 58.7% of BGM Group shares are held by company insiders. Comparatively, 2.8% of Ensysce Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Ensysce Biosciences has lower revenue, but higher earnings than BGM Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BGM Group	$47.90M	0.52	-$19.94M	N/A	N/A
Ensysce Biosciences	$5.07M	1.85	-$10.18M	-$2.76	N/A

Summary

BGM Group beats Ensysce Biosciences on 8 of the 11 factors compared between the two stocks.

Get Ensysce Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ENSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ENSC vs. The Competition

Export

Metric	Ensysce Biosciences	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$9.47M	$12.45B	$7.16B	$14.30B
Dividend Yield	N/A	2.64%	2.57%	11.70%
P/E Ratio	-0.17	794.71	273.30	25.37
Price / Sales	1.85	756.38	650.46	87.69
Price / Cash	N/A	14.86	28.42	34.96
Price / Book	0.76	10.43	10.48	6.24
Net Income	-$10.18M	$2.84B	$3.49B	$358.08M
7 Day Performance	1.78%	-2.39%	-1.09%	-0.70%
1 Month Performance	20.38%	1.37%	0.63%	-2.76%
1 Year Performance	-76.74%	4.50%	20.22%	6.72%

Ensysce Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ENSC Ensysce Biosciences	0.9191 of 5 stars	$0.48 -1.1%	N/A	-77.2%	$9.47M	$5.07M	N/A	10
PYRGF PyroGenesis Canada	N/A	$0.15 +1.5%	N/A	-27.5%	$34.45M	$9.14M	N/A	90	News Coverage Gap Up
UG United-Guardian	1.9864 of 5 stars	$7.12 -0.3%	N/A	-8.2%	$32.78M	$10.55M	13.19	20
MIRA MIRA Pharmaceuticals	0.9718 of 5 stars	$0.78 +1.6%	N/A	-48.1%	$32.10M	N/A	N/A	2	Positive News
TAOX Synaptogenix	0.1944 of 5 stars	$4.01 +3.4%	N/A	-37.2%	$29.07M	$300K	N/A	4	Analyst Downgrade Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ENSC) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ensysce Biosciences (ENSC) Competitors

ENSC vs. PYRGF, UG, MIRA, TAOX, and BGM

How does Ensysce Biosciences compare to PyroGenesis Canada?

Summary

How does Ensysce Biosciences compare to United-Guardian?

Summary

How does Ensysce Biosciences compare to MIRA Pharmaceuticals?

Summary

How does Ensysce Biosciences compare to Synaptogenix?

Summary

How does Ensysce Biosciences compare to BGM Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ENSC vs. The Competition

Ensysce Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ensysce Biosciences (ENSC) Competitors

ENSC vs. PYRGF, UG, MIRA, TAOX, and BGM

How does Ensysce Biosciences compare to PyroGenesis Canada?

Does the media refer more to ENSC or PYRGF?

Is ENSC or PYRGF more profitable?

Which has more volatility and risk, ENSC or PYRGF?

Do analysts prefer ENSC or PYRGF?

Do institutionals and insiders believe in ENSC or PYRGF?

Which has preferable earnings & valuation, ENSC or PYRGF?

Summary

How does Ensysce Biosciences compare to United-Guardian?

Is UG or ENSC more profitable?

Do institutionals & insiders hold more shares of UG or ENSC?

Which has better earnings & valuation, UG or ENSC?

Which has more volatility & risk, UG or ENSC?

Do analysts rate UG or ENSC?

Does the media prefer UG or ENSC?

Summary

How does Ensysce Biosciences compare to MIRA Pharmaceuticals?

Which has higher earnings & valuation, MIRA or ENSC?

Which has more risk and volatility, MIRA or ENSC?

Does the media refer more to MIRA or ENSC?

Do institutionals & insiders have more ownership in MIRA or ENSC?

Is MIRA or ENSC more profitable?

Do analysts prefer MIRA or ENSC?

Summary

How does Ensysce Biosciences compare to Synaptogenix?

Do institutionals and insiders believe in TAOX or ENSC?

Which has better earnings and valuation, TAOX or ENSC?

Do analysts rate TAOX or ENSC?

Which has more risk and volatility, TAOX or ENSC?

Does the media favor TAOX or ENSC?

Is TAOX or ENSC more profitable?

Summary

How does Ensysce Biosciences compare to BGM Group?

Does the media favor BGM or ENSC?

Is BGM or ENSC more profitable?

Do analysts rate BGM or ENSC?

Which has more volatility and risk, BGM or ENSC?

Do insiders and institutionals believe in BGM or ENSC?

Which has higher valuation and earnings, BGM or ENSC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ENSC vs. The Competition

Ensysce Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools